
Qiagen NV (QGEN) Beta Value: Understanding the Market Risk
The price-to-earnings ratio for Qiagen NV (NYSE: QGEN) is above average at 111.79x. The 36-month beta value for QGEN is also noteworthy at 0.65. There
The price-to-earnings ratio for Qiagen NV (NYSE: QGEN) is above average at 111.79x. The 36-month beta value for QGEN is also noteworthy at 0.65. There
In the past week, QGEN stock has gone down by -1.92%, with a monthly decline of 0.00% and a quarterly plunge of -12.65%. The volatility
Qiagen NV (NYSE: QGEN) has a higher price-to-earnings ratio of 107.73x compared to its average ratio. QGEN has 36-month beta value of 0.69. Analysts have
The stock of Qiagen NV (NYSE: QGEN) has increased by 0.86 when compared to last closing price of 39.65.Despite this, the company has seen a
The price-to-earnings ratio for Qiagen NV (NYSE: QGEN) is above average at 105.95x, Company’s 36-month beta value is 0.64.Analysts have differing opinions on the stock,
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.